Logo Logo

Publications by Diacon, Andreas H.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Svensson, Elin M.; Svensson, Robin J.; te Brake, Lindsey H. M.; Böree, Martin J.; Heinrich, Norbert; Konsten, Sarah; Churchyard, Gavin; Dawson, Rodney; Diacon, Andreas H.; Kibiki, Gibson S.; Minja, Lilian T.; Ntingiya, Nyanda E.; Saone, Ian; Gillespie, Stephen H.; Hölscher, Michael; Phillips, Patrick P. J.; Simonsson, Ulrika S. H.; Aarnoutse, Rob (2018): The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis. In: Clinical Infectious Diseases, Vol. 67, No. 1: pp. 34-41

Boeree, Martin J.; Heinrich, Norbert; Aarnoutse, Rob; Diacon, Andreas H.; Dawson, Rodney; Rehal, Sunita; Kibiki, Gibson S.; Churchyard, Gavin; Sanne, Ian; Ntinginya, Nyanda E.; Minja, Lilian T.; Hunt, Robert D.; Charalambous, Salome; Hanekom, Madeleine; Semvua, Hadija H.; Mpagama, Stellah G.; Manyama, Christina; Mtafya, Bariki; Reither, Klaus; Wallis, Robert S.; Venter, Amour; Narunsky, Kim; Mekota, Anka; Henne, Sonja; Colbers, Angela; Plemper van Balen, Georgette; Gillespie, Stephen H.; Phillips, Patrick P. J.; Hölscher, Michael (2017): High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial. In: Lancet infectious Diseases, Vol. 17, No. 1: pp. 39-49

Phillips, Patrick P. J.; Dooley, Kelly E.; Gillespie, Stephen H.; Heinrich, Norbert; Stout, Jason E.; Nahid, Payam; Diacon, Andreas H.; Aarnoutse, Rob E.; Kibiki, Gibson S.; Boeree, Martin J.; Hoelscher, Michael (2016): A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP). In: BMC Medicine 14:51 [PDF, 2MB]

This list was generated on Sat Jan 16 00:29:23 2021 CET.